Profile
KDLY LH NVST CON BBNX NEUE
Company Name Kindly MD, Inc. Laboratory Corporation of America Holdings Envista Holdings Corp Concentra Group Holdings Parent, Inc. Beta Bionics, Inc. NeueHealth, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services Medical - Equipment & Services
Market Cap $72.69M $21.68B $3.46B $2.62B $587.91M $61.33M
Employees 0.02K 60.90K 12.30K 8.76K 0.35K 0.99K
CEO Timothy Pickett Adam H. Schechter Paul A. Keel William Keith Newton Sean T. Saint PE George Lawrence Mikan III
Ratings
KDLY LH NVST CON BBNX NEUE
Quant Rating Score 1 3 2 3 2 1
Quant Rating Strong Sell Neutral Sell Neutral Sell Strong Sell
Trading
KDLY LH NVST CON BBNX NEUE
Last Close $12.23 $253.63 $20.72 $19.9 $12.67 $6.83
High 52 $24.94 $264.27 $22.33 $24.45 $23.52 $7.54
Low 52 $0.83 $206.17 $14.78 $19.47 $9.71 $3.82
Price vs. 52 Week High -50.96 % -4.03 % -7.21 % -18.61 % -46.13 % -9.42 %
Price vs. 52 Week Low 1373.49 % 23.02 % 40.19 % 2.21 % 30.48 % 78.8 %
Total Return
KDLY LH NVST CON BBNX NEUE
1 Month Return -27.76 % -2.41 % 7.75 % -8.4 % -34.99 % -0.29 %
3 Month Return 611.05 % 14.53 % 34.02 % -1.92 % 16.13 % 11.6 %
6 Month Return 755.24 % 9.32 % 11.52 % 0.86 % 0 % -6.82 %
9 Month Return 779.86 % 17.21 % 14.29 % -0.95 % 0 % 16.75 %
YTD Return 886.29 % 10.6 % 7.41 % 0.61 % 0 % -7.95 %
1 Year Return 410.65 % 22.97 % 23.78 % 0 % 0 % 33.14 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
KDLY LH NVST CON BBNX NEUE
Dividend Yield Percentage (TTM) - 1.11 % - 0.92 % - -
Dividend Paid and Capex Coverage Ration (TTM) -9.54 % 2.25 % 10.33 % 0.15 % -35.69 % -29 %
Dividend Per Share (TTM) - 2.88 % - 0.19 % - -
Payout Ratio (TTM) - 33.2 % - 987.07 % - -
Growth
KDLY LH NVST CON BBNX NEUE
Asset Growth 234.61 % -18.99 % 8.04 % 35.99 %
Gross Profit Growth 1763.37 % -5.36 % 20.16 % 468.93 %
Revenue Growth -27.83 % -2.18 % 3.38 % 442.93 %
Revenue 3 Year 20.29 % -6.32 % 8.4 % 28465.39 %
Revenue 5 Year 20.29 % -27.83 % 8.4 % 28465.39 %
Revenue 10 Year 20.29 % -19.08 % 8.4 % 28465.39 %
EBIT Growth -106.47 % -12315.29 % 5.01 % -26.22 %
Net Income Growth -123.66 % -1016.37 % -7.45 % -24.17 %
Net Income 3 Yeari Growth Per Share -2783.05 % -497.4 % -21.22 % 33.6 %
Net Income 5 Yeari Growth Per Share -2783.05 % -506.59 % -21.22 % 33.6 %
Net Income 10 Yeari Growth Per Share -2783.05 % -469.22 % -21.22 % 33.6 %
Operating Income Growth -106.56 % -3395.87 % 6.05 % -26.22 %
Operating Cash Flow Growth (CFG) -583.86 % 22.05 % 17.23 % -48.78 %
Operating 3 Year CFG -2903.43 % -19.52 % -6.62 % 37.05 %
Operating 5 Year CFG -2903.43 % -33.04 % -6.62 % 37.05 %
Operating 10 Year CFG -2903.43 % -27.55 % -6.62 % 37.05 %
EPS Growth -148.15 % -983.33 % -7.75 % -3.49 %
EPS Diluted Growth -148.15 % -983.33 % -7.75 % -3.49 %
Book Value Per Share 2723.84 % -31.85 % -74.93 % 8.07 %
Share Holder 3 Year Equity Growth Per Share 941.63 % -32.29 % - 359.09 %
Share Holder 5 Year Equity Growth Per Share 941.63 % -34.43 % - 359.09 %
Share Holder 10 Year Equity Growth Per Share 941.63 % - - 359.09 %
Dividend Per Share Growth - - 24780.58 % -
Dividend 3 Year Growth Per Share - - 22616.4 % -
Dividend 5 Year Growth Per Share - - 22616.4 % -
Dividend 10 Year Growth Per Share - - 22616.4 % -
Debt Growth 23.15 % -6.4 % 115.62 % 71.8 %
Free Cash Flow Growth -565.47 % 39.17 % 27.5 % -57.3 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
KDLY LH NVST CON BBNX NEUE
Gross Profit Margin TTM 48.92 % 27.42 % 54.14 % 27.06 % 54.31 % 22.17 %
Return on Assets TTM -170.59 % 4.15 % -20.57 % 5.73 % -20.4 % -16.04 %
Return on Equity TTM -146.24 % 8.98 % -37.41 % 34.18 % -57.31 % 21.99 %
Return on Capital Employed TTM -207.45 % 7.1 % 2.73 % 12.85 % -16.21 % 48.49 %
Net Income Per EBT TTM 100 % 77.97 % 103.04 % 71.18 % 100 % 134.07 %
EBT Per Ebit TTM 105.35 % 84.98 % -869.32 % 71.02 % 132.32 % 131.22 %
EBIT Per Revenue TTM -168.04 % 8.37 % 5.01 % 16.01 % -76.95 % -9 %
Cash Flow To Debt Ratio TTM -559.06 % 25.06 % 19 % 46.67 % -665.3 % -9554.9 %
Receivables Turnover TTM 181.47 5.79 6.37 7.49 6.15 21.75
Payables Turnover TTM - 13.32 7.02 40.08 8.96 129.55
Inventory Turnover TTM 791.15 19.59 4.39 - 1.97 -
Fixed Asset Turnover TTM 359.19 % 426.34 % 598.45 % 288.43 % 571.02 % 8168.43 %
Asset Turnover TTM 96.37 % 74.86 % 45.81 % 70.84 % 20.03 % 101.3 %
Operating Cash Flow Per Share TTM -0.62 19.55 1.72 1.91 -1.51 -11.15
Free Cash Flow Per Share TTM -0.68 13.78 1.55 1.41 -1.55 -11.53
Cash Per Share TTM 18.93 % 441.87 % 624.88 % 41.15 % 753.62 % 1693.17 %
Operating Cash Flow Sales Ratio TTM -150.8 % 12.4 % 11.84 % 12.5 % -68.52 % -10.53 %
Free Cash Flow Operating Cash Flow Ratio TTM 110.48 % 70.5 % 90.32 % 74.01 % 102.8 % 103.45 %
Cash Flow Coverage Ratios TTM -559.06 % 25.06 % 19 % 46.67 % -665.3 % -9554.9 %
Price To Free Cash Flows Ratio TTM -17.66 18.82 12.9 14.65 -12.33 -0.62
Price To Operating Cash Flows Ratio TTM -19.52 13.25 11.86 10.71 -8.98 -0.62
Price Cash Flow Ratio TTM -19.52 13.25 11.86 10.71 -8.98 -0.62
Income Statement (TTM)
KDLY LH NVST CON BBNX NEUE
Revenue $0B $13.01B $2.51B $1.9B $0.07B $0.94B
Gross Profit $0B $3.5B $1.37B $0.53B $0.04B $0.19B
Gross Profit Ratio 96.96% 26.92% 54.68% 27.79% 55.11% 20.77%
EBITDA $-0B $1.81B $-0.88B $0.37B $-0.04B $-0.08B
Net Income $-0B $0.75B $-1.12B $0.17B $-0.05B $-0.13B
EPS Diluted -0.67 8.84 -6.5 1.31 -8.6 -22.65
Balance Sheet (MRQ)
KDLY LH NVST CON BBNX NEUE
Long Term Debt $0B $6.08B $1.28B $1.87B $0.01B $0.2B
Total Liabilities $0B $10.31B $2.42B $2.22B $0.07B $0.93B
Total Equity $0B $8.07B $2.93B $0.3B $0.08B $-0.39B
Total Investments $0B $0.02B $0B $0B $0.07B $0.01B
Total Debt $0B $7.27B $1.55B $1.95B $0.01B $0.2B
Total Assets $0B $18.38B $5.35B $2.52B $0.15B $0.54B
Cash Flow Statement (TTM)
KDLY LH NVST CON BBNX NEUE
Net Income $-0B $0.75B $-1.12B $0.17B $-0.05B $-0.1B
Inventory $0B $-0.01B $0B $0B $-0.01B $0B
Dividends Paid $0B $-0.24B $0B $-1.54B $0B $0B
Operating Cash Flow $-0B $1.59B $0.34B $0.27B $-0.05B $-0.12B
Capital Expenditure $-0B $-0.49B $-0.03B $-0.06B $-0B $-0B
Related Stocks
Ticker Name Price
BBNX Beta Bionics, Inc. Common Stock 12.67
CON Concentra Group Holdings Parent, Inc. 19.9
LH Laboratory Corporation of America Holdings 249.62
NEUE NeueHealth, Inc. 6.83
NVST Envista Holdings Corporation 20.2
Unlock